Healthcare >> Analyst Interviews >> December 5, 2001
SERGIO TRAVERSA is a Portfolio Manager with the Merlin BioMed Group
focusing on the global pharmaceutical sector. He was previously a
Managing Director in the Health Care Equity department of ING Barings
U.S. and a Pharmaceutical Analyst with Mehta and Isaly and Mehta
Partners. Prior to that he was associated with Johnson & Johnson and Eli
Lilly. Mr. Traversa received a Doctor of Pharmacy degree from the
University of Turin and an MBA from the Stern School of Business at New
York University. Profile
TWST: What are the most important issues that investors should befocused on as they assess the opportunities for investment in the
pharmaceutical industry, not just in 2002, but looking out longer